Inventor · disambiguated record
Cedric Francois
Also filed as: FRANCOIS CEDRIC
43 granted patents·57 pending applications·450 citations·filing 2003–2025
98Inventor score
Files withAPELLIS PHARMACEUTICALS INC48FRANCOIS CEDRIC17POTENTIA PHARMACEUTICALS INC6APELLIS HOLDINGS LLC5REVON SYSTEMS INC4
Top patents by PatentIndex Score
100 records- 0197US9421240B2Compstatin analogs for treatment of neuropathic painFRANCOIS CEDRIC·Filed 2011·Granted Aug 23, 2016·41 cites·9 claims
- 0296US9271899B2Methods, articles and kits for allergic desensitization, via the oral mucosaFRANCOIS CEDRIC·Filed 2011·Granted Mar 1, 2016·23 cites·20 claims
- 0396US8580735B2Local complement inhibition for treatment of complement-mediated disordersFRANCOIS CEDRIC·Filed 2008·Granted Nov 12, 2013·50 cites·21 claims
- 0495US9056076B2Method of treating age-related macular degeneration comprising administering a compstatin analogDESCHATELETS PASCAL·Filed 2012·Granted Jun 16, 2015·39 cites·19 claims
- 0595US8168584B2Methods of treating age-related macular degeneration by compstatin and analogs thereofDESCHATELETS PASCAL·Filed 2006·Granted May 1, 2012·44 cites·58 claims
- 0694US10407466B2Methods of selecting compstatin mimeticsAPELLIS PHARMACEUTICALS INC·Filed 2017·Granted Sep 10, 2019·12 cites·2 claims
- 0794US9956132B2Apparatus and methods for assisting breathingAPELLIS HOLDINGS LLC·Filed 2017·Granted May 1, 2018·18 cites·37 claims
- 0893US11338013B2Combination therapy for C3 inhibitionAPELLIS PHARMACEUTICALS INC·Filed 2017·Granted May 24, 2022·7 cites·19 claims
- 0993US11292815B2Cell-reactive, long-acting, or targeted compstatin analogs and related compositions and methodsAPELLIS PHARMACEUTICALS INC·Filed 2020·Granted Apr 5, 2022·2 cites·11 claims
- 1093US11001610B2Cell-reactive, long-acting, or targeted compstatin analogs and uses thereofAPELLIS PHARMACEUTICALS INC·Filed 2018·Granted May 11, 2021·4 cites·23 claims
- 1193US10875893B2Cell-reactive, long-acting, or targeted compstatin analogs and related compositions and methodsAPELLIS PHARMACEUTICALS INC·Filed 2018·Granted Dec 29, 2020·10 cites·9 claims
- 1293US10308687B2Cell-penetrating compstatin analogs and uses thereofAPELLIS PHARMACEUTICALS INC·Filed 2014·Granted Jun 4, 2019·14 cites·13 claims
- 1393US10035822B2Cell-reactive, long-acting, or targeted compstatin analogs and related compositions and methodsAPELLIS PHARMACEUTICALS INC·Filed 2013·Granted Jul 31, 2018·15 cites·12 claims
- 1492US12290566B2Dosing regimens and related compositions and methodsAPELLIS PHARMACEUTICALS INC·Filed 2023·Granted May 6, 2025·2 cites·20 claims
- 1592US11844841B2Dosing regimens and related compositions and methodsAPELLIS PHARMACEUTICALS INC·Filed 2021·Granted Dec 19, 2023·4 cites·26 claims
- 1692US11407789B2Cell-penetrating compstatin analogs and uses thereofAPELLIS PHARMACEUTICALS INC·Filed 2020·Granted Aug 9, 2022·2 cites·11 claims
- 1792US10125171B2Cell-reactive, long-acting, or targeted compstatin analogs and uses thereofFRANCOIS CEDRIC·Filed 2012·Granted Nov 13, 2018·16 cites·21 claims
- 1892US9623239B2Apparatus and methods for assisting breathingAPELLIS HOLDINGS LLC·Filed 2015·Granted Apr 18, 2017·16 cites·20 claims
- 1992US8043609B2Viral complement control proteins for eye disordersPOTENTIA PHARMACEUTICALS INC·Filed 2006·Granted Oct 25, 2011·14 cites·14 claims
- 2090US9724271B2Methods and articles for preventing or reducing risk of developing a hyperallergenic immune systemFRANCOIS CEDRIC·Filed 2011·Granted Aug 8, 2017·8 cites·17 claims
- 2190US7947267B2Viral complement control proteins for eye disordersPOTENTIA PHARMACEUTICALS INC·Filed 2005·Granted May 24, 2011·19 cites·59 claims
- 2289US9291622B2Complement assays and uses thereofZHANG ZHOUNING·Filed 2010·Granted Mar 22, 2016·24 cites·20 claims
- 2388US11040107B2Dosing regimens and related compositions and methodsAPELLIS PHARMACEUTICALS INC·Filed 2018·Granted Jun 22, 2021·9 cites·24 claims
- 2488US10941184B2Cell-penetrating compstatin analogs and uses thereofAPELLIS PHARMACEUTICALS INC·Filed 2019·Granted Mar 9, 2021·3 cites·11 claims
- 2588US2025282823A1Cell-reactive, long-acting, or targeted compstatin analogs and related compositions and methodsAPELLIS PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 2687US9174046B2Apparatus and methods for assisting breathingFRANCOIS CEDRIC·Filed 2012·Granted Nov 3, 2015·20 cites·15 claims
- 2786US11013782B2Methods of treating chronic disorders with complement inhibitorsAPELLIS PHARMACEUTICALS INC·Filed 2019·Granted May 25, 2021·1 cites·24 claims
- 2883US10039802B2Methods of treating chronic disorders with complement inhibitorsFRANCOIS CEDRIC·Filed 2012·Granted Aug 7, 2018·5 cites·23 claims
- 2983US2024076317A1Cell-reactive, long-acting, or targeted compstatin analogs and uses thereofAPELLIS PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 3082US11903994B2Dosing regimensAPELLIS PHARMACEUTICALS INC·Filed 2016·Granted Feb 20, 2024·4 cites·10 claims
- 3181US11101026B2Schedule-based electronic medical record modules, applications, and uses thereofREVON SYSTEMS LLC·Filed 2015·Granted Aug 24, 2021·6 cites·20 claims
- 3280US12329716B2Apparatus and methods for assisting breathingAPELLIS HOLDINGS LLC·Filed 2022·Granted Jun 17, 2025·0 cites·19 claims
- 3380US8198020B2Compositions and methods for enhancing phagocytosis or phagocyte activityFRANCOIS CEDRIC·Filed 2004·Granted Jun 12, 2012·17 cites·59 claims
- 3479US10702445B2Apparatus and methods for assisting breathingAPELLIS HOLDINGS LLC·Filed 2018·Granted Jul 7, 2020·1 cites·38 claims
- 3579US2025281347A1Apparatus and methods for assisting breathingLIBERATE MEDICAL LLC·Filed 2025·Application pending·0 cites
- 3678US2023091471A1Cell-reactive, long-acting, or targeted compstatin analogs and related compositions and methodsAPELLIS PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 3776US11661441B2Cell-reactive, long-acting, or targeted compstatin analogs and uses thereofAPELLIS PHARMACEUTICALS INC·Filed 2021·Granted May 30, 2023·0 cites·34 claims
- 3876US2023075121A1Cell-penetrating compstatin analogs and uses thereofAPELLIS PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 3975US11712460B2Methods of treating chronic disorders with complement inhibitorsAPELLIS PHARMACEUTICALS INC·Filed 2021·Granted Aug 1, 2023·0 cites·19 claims
- 4074US2022249663A1Methods and compositions for cancer treatment and treatment selectionAPELLIS PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 4174US2024285783A1Dosing regimens and related compositions and methodsAPELLIS PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 4273US12458695B2Dosing regimens and related compositions and methodsAPELLIS PHARMACEUTICALS INC·Filed 2025·Granted Nov 4, 2025·0 cites·30 claims
- 4373US11529283B2Apparatus and methods for assisting breathingAPELLIS HOLDINGS LLC·Filed 2020·Granted Dec 20, 2022·0 cites·21 claims
- 4473US10696718B2Compstatin analogs for treatment of neuropathic painAPELLIS PHARMACEUTICALS INC·Filed 2018·Granted Jun 30, 2020·0 cites·3 claims
- 4572US2022280638A1Methods and articles for allergic desensitization via the oral mucosaALLOVATE LLC·Filed 2022·Application pending·0 cites
- 4671US2020325175A1Cell-reactive, long-acting, or targeted compstatin analogs and related compositions and methodsAPELLIS PHARMACEUTICALS INC·Filed 2019·Application pending·0 cites
- 4770US2022088131A1Compositions and methods relating to c5l2KING S COLLEGE LONDON·Filed 2021·Application pending·0 cites
- 4870US2021107944A1Compstatin analogs for treatment of neuropathic painAPELLIS PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 4968US2023009757A1Combination therapy for c3 inhibitionAPELLIS PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 5067US11291407B2Detection of high risk drusenAPELLIS PHARMACEUTICALS INC·Filed 2020·Granted Apr 5, 2022·0 cites·7 claims
Showing the top 50 of 100 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Cedric Francois files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →